Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × margetuximab × Breast × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 75 Letrozole 55 Trastuzumab 53 Fulvestrant 53 pembrolizumab 50 Carboplatin 46 Cyclophosphamide 43 pertuzumab 38 palbociclib 37 Anastrozole 33 Capecitabine 32 Radiotherapy 27 Tamoxifen 26 exemestane 24 Magnetic Resonance Spectroscopy 24 olaparib 23 Doxorubicin 23 abemaciclib 22 Docetaxel 22 Epirubicin 20 ribociclib 19 Alpelisib 19 130-nm albumin-bound paclitaxel 19 Gemcitabine 18 eribulin 17 durvalumab 16 atezolizumab 16 Taxes 16 Surveys and Questionnaires 16 Specimen Handling 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04425018 2025-11-18

MARGOT

Dana-Farber Cancer Institute

Phase 2 Active not recruiting

174 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡